TPO‐RA treated patients demonstrated transient platelet surges peaking at 1 week postinfection, returning to baseline within 2–3 weeks, contrasting sharply with thrombocytopenia patterns in non‐ITP populations. The gene discussed is TPO; the disease is autoimmune thrombocytopenic purpura.